1.A known allergy to IMP <br/ >2. Any known contraindication to IMP <br/ >3. Patient currently prescribed inhaled or systemic corticosteroids <br/ >4.Recent use, within the previous 7 days of inhaled or systemic corticosteroids <br/ >5. Patient needs hospitalisation at time of study consent <br/ >6. Any other significant disease or disorder which, in the opinion of the Investigator, may either put the participants at risk because of participation in the trial, or may influence the result of the trial, or the participantâ??s ability to participate in the trial. <br/ >7. Participants who have participated in another research trial involving an investigational product in the past 12 weeks

1.A known allergy to IMP <br/ >2. Any known contraindication to IMP <br/ >3. Patient currently prescribed inhaled or systemic corticosteroids <br/ >4.Recent use, within the previous 7 days of inhaled or systemic corticosteroids <br/ >5. Patient needs hospitalisation at time of study consent <br/ >6. Any other significant disease or disorder which, in the opinion of the Investigator, may either put the participants at risk because of participation in the trial, or may influence the result of the trial, or the participantâ??s ability to participate in the trial. <br/ >7. Participants who have participated in another research trial involving an investigational product in the past 12 weeks

N/A

N/A

1.A known allergy to IMP <br/ >2. Any known contraindication to IMP <br/ >3. Patient currently prescribed inhaled or systemic corticosteroids <br/ >4.Recent use, within the previous 7 days of inhaled or systemic corticosteroids <br/ >5. Patient needs hospitalisation at time of study consent <br/ >6. Any other significant disease or disorder which, in the opinion of the Investigator, may either put the participants at risk because of participation in the trial, or may influence the result of the trial, or the participantâ??s ability to participate in the trial. <br/ >7. Participants who have participated in another research trial involving an investigational product in the past 12 weeks

1.A known allergy to IMP <br/ >2. Any known contraindication to IMP <br/ >3. Patient currently prescribed inhaled or systemic corticosteroids <br/ >4.Recent use, within the previous 7 days of inhaled or systemic corticosteroids <br/ >5. Patient needs hospitalisation at time of study consent <br/ >6. Any other significant disease or disorder which, in the opinion of the Investigator, may either put the participants at risk because of participation in the trial, or may influence the result of the trial, or the participantâ??s ability to participate in the trial. <br/ >7. Participants who have participated in another research trial involving an investigational product in the past 12 weeks